North America's leading commercial stem cells & regenerative medicine event


Where stem cell, regenerative medicine, cell & gene therapy biotechs gather, discussing strategies to develop & commercialize the next gen cure for unmet needs

 

SPONSOR NOW   REGISTER NOW

 

 

Meet key industry leaders 

 

 

Join 300+ attendees from stem cell, regenerative medicine, cell & gene therapy biotechs 

Discuss the hottest industry topics and make new connections

Hear from 70+ speakers

Learn from the best and brightest in the industry.

Take advantage of 13+ hours of networking

With networking drinks receptions, 1-2-1 partnering, a networking app and speed networking... we've got it all! Take part in a variety of formal and informal opportunities.

 

SPONSORSHIP PROSPECTUS

 

 

Position yourself as an industry leader

Contact us today to secure your position as a partner, sponsor or exhibitor at the show.

It's more than great content

This event is an opportunity to showcase your services to your target market. By sponsoring our event, you can  develop relationships, make sales and raise your company's profile.

Lead Generation Programme

Sponsoring involves more than just a two day event. We have access to the Total BioPharma community of almost 250,000 people. You provide us with great content, and we'll distribute it through email, our blog and multiple social media channels.

1-2-1 Partnering

Your success at the show is dependent on the quality relationships you build. Take a look at the delegate list before the event, decide who you want to meet and we'll make it happen.

 

SPONSORSHIP PROSPECTUS

 

Addressing unmet needs if only…


Despite its turns and tumbles, the stem cell and regenerative medicine sector thrives. Cancer, Alzheimer’s, rare diseases and a host of other diseases remain unsolved and the key could be in cell therapies. But challenges in ethics, clinical trial size, living raw materials, regulators’ not knowing how to assess this nascent space, hamper stem cell therapies’ way to market.

Are you ready? Top biopharma gather to tackle common barriers to commercial success in the the US stem cells & regenerative medicine market such as high development costs, time-consuming R&D and lengthy clinical trials.  

 

Stem Cells & Regenerative Medicine Congress 2015

Stem Cells & Regenerative Medicine Congress 2015

Stem Cells & Regenerative Medicine Congress 2015

Stem Cells & Regenerative Medicine Congress 2015

Stem Cells & Regenerative Medicine Congress 2015

Our Sponsors


  • Gold Sponsor

    Octane Medical Group at Stem Cells & Regenerative Medicine Congress USA
  • Exhibitor

    WuXi AppTec, Inc at Stem Cells & Regenerative Medicine Congress USA
  • Exhibitor

    Saint Gobain Life Sciences at Stem Cells & Regenerative Medicine Congress USA

SEE OUR SPONSORS

 

Sylvia Julien presentation image

Minimising the immunogenicity of biopharmaceuticals: Current status of monitoring immunogenicity across the R&D value chain

At the 2014 Exploratory Clinical Development World Europe, Sylvia Julien, Principal Scientist, Senior Project Leader Global Scientific Affairs and Strategic Sourcing, Ipsen,  gave a presentation on ...

The post Minimising the immunogenicity of biopharmaceuticals: Current status of monitoring immunogenicity across the R&D value chain appeared first on Total Biopharma.

The evolution of antibiotic resistance

Antibiotics crisis – will PPPs solve the need for super drugs?

It is an alarming fact that AMR (AntiMicrobial Resistance) claims 23,000 Americans lives each year. According to a report commissioned by British Prime Minister David ...

The post Antibiotics crisis – will PPPs solve the need for super drugs? appeared first on Total Biopharma.

High Potency API Facts and Figures

Download the Infographic: Facts and Figures of High Potency API Manufacturing

In last week’s blog post we covered the A-Z of HPAPI – High Potency API – giving you a preparative guide ahead of this November’s ...

The post Download the Infographic: Facts and Figures of High Potency API Manufacturing appeared first on Total Biopharma.

Join the Community

Innovation and strategy for pharmaceutical, biotech and R&D

Sign Up to Our Newsletter